ArticleBlood science (Baltimore, Md.)2023
The opposite impact of Janus kinase inhibitor Ruxolitinib on the function of bone marrow mesenchymal stem cells and immune cells in acute GVHD recipients.
Defu ZengPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.